Evogene (EVGN) Reaches New 1-Year Low at $2.37
Evogene Ltd (NASDAQ:EVGN)’s share price reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $2.37 and last traded at $2.39, with a volume of 2732 shares. The stock had previously closed at $2.40.
Separately, ValuEngine raised Evogene from a “hold” rating to a “buy” rating in a report on Wednesday, November 7th.
A hedge fund recently raised its stake in Evogene stock. ARK Investment Management LLC increased its stake in shares of Evogene Ltd (NASDAQ:EVGN) by 169.2% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 167,347 shares of the biotechnology company’s stock after buying an additional 105,188 shares during the quarter. ARK Investment Management LLC owned about 0.65% of Evogene worth $479,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 35.29% of the company’s stock.
Evogene Company Profile (NASDAQ:EVGN)
Evogene Ltd., a biotechnology company, focuses on the enhancement of crop productivity and performance in the United States, Germany, and internationally. It operates through three segments: Evogene, Evofuel, and Biomica. The Evogene segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance.
Recommended Story: How Investors Use a Balance Sheet
Receive News & Ratings for Evogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evogene and related companies with MarketBeat.com's FREE daily email newsletter.